Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 11:27 am Purchase |
2022-12-30 | 13G | Myriad Genetics, Inc. MYGN |
The Vanguard Group | 9,311,761 11.490% |
162,240 (+1.77%) |
Filing History |
| 2023-02-06 2:53 pm Purchase |
2022-12-30 | 13G | Myriad Genetics, Inc. MYGN |
Wellington Management Group LLP | 6,787,223 8.380% |
2,461,448 (+56.90%) |
Filing History |
| 2023-01-31 09:19 am Purchase |
2022-12-31 | 13G | Myriad Genetics, Inc. MYGN |
STATE STREET CORP STT |
5,020,423 6.200% |
610,020 (+13.83%) |
Filing History |
| 2023-01-23 3:52 pm Sale |
2022-12-31 | 13G | Myriad Genetics, Inc. MYGN |
BlackRock Inc. BLK |
14,356,099 17.700% |
-328,688 (-2.24%) |
Filing History |
| 2023-01-09 5:09 pm Sale |
2022-12-31 | 13G | Myriad Genetics, Inc. MYGN |
EARNEST PARTNERS LLC | 3,304,456 4.100% |
-3,011,909 (-47.68%) |
Filing History |
| 2022-05-12 4:06 pm Purchase |
2022-05-02 | 13G | Myriad Genetics, Inc. MYGN |
Camber Capital Management LP | 4,700,000 5.850% |
1,950,000 (+70.91%) |
Filing History |
| 2022-02-14 09:39 am Sale |
2021-12-31 | 13G | Myriad Genetics, Inc. MYGN |
Camber Capital Management LP | 2,750,000 3.440% |
-2,250,000 (-45.00%) |
Filing History |
| 2022-02-11 3:19 pm Purchase |
2021-12-31 | 13G | Myriad Genetics, Inc. MYGN |
STATE STREET CORP STT |
4,410,403 5.520% |
694,873 (+18.70%) |
Filing History |
| 2022-02-10 5:37 pm Sale |
2021-12-31 | 13G | Myriad Genetics, Inc. MYGN |
EARNEST PARTNERS LLC | 6,316,365 7.900% |
-415,064 (-6.17%) |
Filing History |
| 2022-02-10 08:27 am Purchase |
2021-12-31 | 13G | Myriad Genetics, Inc. MYGN |
The Vanguard Group | 9,149,521 11.460% |
852,657 (+10.28%) |
Filing History |
| 2022-02-04 09:21 am Purchase |
2021-12-31 | 13G | Myriad Genetics, Inc. MYGN |
Wellington Management Group LLP | 4,325,775 5.420% |
952,575 (+28.24%) |
Filing History |
| 2022-01-27 1:59 pm Unchanged |
2021-12-31 | 13G | Myriad Genetics, Inc. MYGN |
BlackRock Inc. BLK |
14,684,787 18.400% |
0 (Unchanged) |
Filing History |
| 2022-01-25 6:45 pm Purchase |
2021-12-31 | 13G | Myriad Genetics, Inc. MYGN |
BlackRock Inc. BLK |
14,684,787 18.400% |
2,182,867 (+17.46%) |
Filing History |
| 2021-02-16 4:03 pm Sale |
2020-12-31 | 13G | Myriad Genetics, Inc. MYGN |
D. E. Shaw & Co., L.P. | 3,215,449 4.300% |
-576,079 (-15.19%) |
Filing History |
| 2021-02-16 3:33 pm Purchase |
2020-12-31 | 13G | Myriad Genetics, Inc. MYGN |
EARNEST PARTNERS LLC | 6,731,429 9.000% |
6,731,429 (New Position) |
Filing History |
| 2021-02-16 08:20 am Purchase |
2020-12-31 | 13G | Myriad Genetics, Inc. MYGN |
Camber Capital Management LP | 5,000,000 6.650% |
1,000,000 (+25.00%) |
Filing History |
| 2021-02-16 08:19 am Sale |
2020-12-31 | 13G | Myriad Genetics, Inc. MYGN |
STATE STREET CORP STT |
3,715,530 4.940% |
-170,746 (-4.39%) |
Filing History |
| 2021-02-10 11:28 am Sale |
2020-12-31 | 13G | Myriad Genetics, Inc. MYGN |
The Vanguard Group | 8,296,864 11.030% |
-23,710 (-0.28%) |
Filing History |
| 2021-01-25 4:49 pm Sale |
2020-12-31 | 13G | Myriad Genetics, Inc. MYGN |
BlackRock Inc. BLK |
12,501,920 16.600% |
-250,199 (-1.96%) |
Filing History |